Maria Vittoria Dieci

Also affiliated with Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group”.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2021)10.1038/s41523-021-00346-1

N/A

4.9DataRank · unranked

281 citations

Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner +73 more

Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial

European Journal of Cancer(2021)10.1016/j.ejca.2021.05.018

N/A

1.4DataRank · unranked

43 citations

Maria Vittoria Dieci, Gaia Griguolo, Federica Miglietta, Fabio Girardi, Giancarlo Bisagni +13 more

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00152-4

N/A

1.3DataRank · unranked

47 citations

Amir Sonnenblick, Elisa Agostinetto, Raphaëlle Bas, Hee Jeong Kim, Maria Alice Franzoi +44 more

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-0156-0

N/A

0.801DataRank · unranked

208 citations

Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen +95 more

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

The Lancet Oncology(2020)10.1016/s1470-2045(20)30450-2

N/A

0.650DataRank · unranked

75 citations

Valentina Guarneri, Laia Paré, Gaia Griguolo, Tomás Pascual, Maria Vittoria Dieci +34 more

Pregnancy After Breast Cancer in Young BRCA Carriers

JAMA(2024)10.1001/jama.2023.25463

N/A

0.614DataRank · unranked

59 citations

Eva Blondeaux, Elisa Agostinetto, Anne-Sophie Hamy, Hee Jeong Kim, Antonio Di Meglio +199 more

Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study

Cancer(2024)10.1002/cncr.35323

N/A

0DataRank · unranked

20 citations

Eva Blondeaux, Chiara Molinelli, Raphaëlle Bas, Hee Jeong Kim, Antonio Di Meglio +40 more

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Annals of Oncology(2024)10.1016/j.annonc.2024.06.009

N/A

0DataRank · unranked

28 citations

Marco Bruzzone, R. Bas, Hyun Jin Kim, Antonio Di Meglio, Rinat Bernstein‐Molho +41 more